Trial intelligence / Profile preview

Acipimox in Acute Heart Failure

NCT00449423Phase 2Terminated

Sponsor
Aarhus University
Start
Mar 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acipimox in Acute Heart Failure (AHF), sponsored by Aarhus University. Started Mar 2007; status: terminated.

02

Drugs

acipimox
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on NCT00449423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00449423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call